CVS · 8-K · 20260805PR000097
GLP-1 Support Expansion
CVS HEALTH Corp · 2026-08-05 · Importance 31 · Surprise 42 · In source text
CVS Health launched a comprehensive GLP-1 support approach across CVS Pharmacy and MinuteClinic locations. Expanded pharmacy support is intended to help patients access GLP-1 treatments and remain on therapy, while a new $29 MinuteClinic virtual visit allows eligible adults to be evaluated by licensed clinicians and, when clinically appropriate, receive prescriptions. CVS Pharmacy also participates in the CMS Medicare GLP-1 Bridge program, under which eligible Medicare beneficiaries can access certain GLP-1 medications for $50 per month through December 31, 2027. CVS Caremark expanded GLP-1 options in its most common commercial formularies to support affordable access to FDA-approved weight-management medications.
Key facts
- CVS Health launched expanded GLP-1 pharmacy support and a $29 MinuteClinic virtual visit for eligible adults to evaluate and potentially prescribe GLP-1 therapy source
- CVS Pharmacy participates in the Centers for Medicare & Medicaid Services Medicare GLP-1 Bridge program which runs through December 31, 2027 source
- Eligible Medicare beneficiaries in the Medicare GLP-1 Bridge program can access certain GLP-1 medications for $50 per month source
- CVS Caremark updated its most common commercial formularies, expanding GLP-1 options for members source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | CVS Health launched expanded GLP-1 pharmacy support and a $29 MinuteClinic virtual visit for eligible adults to evaluate and potentially… |